RxDoctor Payments Data

Amanda-Gay Edwards, PA

Medical · Washington, DCNPI 1841784691

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,576 of the $4,479 with a category attached, or 79.8%. 15 manufacturers reported payments, led by Medtronic at 26.4% of the total. 2025 is the largest year on record at $1,541, 3.0 times the $512 reported in 2021. Among medical clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,479in general payments, 2019–2025

Across 112 payments — averaging $39.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$941
  • Abbott$839
  • AbbVie$631
  • Relievant Medsystems, Inc.$363
  • SPR Therapeutics, Inc$179
  • plus $343 from 9 others

What the payments were for

  • Travel & lodging$85819%
  • Food & beverage$3,57680%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,479 in reported general payments places this provider in the 95th percentile of 87 medical providers in District of Columbia.

See all medical providers in District of Columbia

Medicare billing

Part B allowed, 2024
$41,795
Medicare patients
88
Services billed
552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine112$6,584
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen322$6,491
Gabapentin439$6,203
Pregabalin216$4,080
Tizanidine Hcl130$3,777
OxycontinOxycodone Hcl11$3,018
Cyclobenzaprine Hcl361$2,995
Duloxetine Hcl175$2,919
Diclofenac Sodium68$2,306
Oxycodone Hcl181$2,265
Tramadol Hcl154$1,646
Baclofen57$1,630
Naloxone Hcl26$1,620
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$923
Methocarbamol86$885

Paid to pharmacies, not to this prescriber.

Other medical in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →